Search
AbbVie Inc
ABBVAdd to Watchlist
256.910USD
+3.610+1.43%
Close 07-23 16:00（ET）Quotes delayed by 15 min
453.89BMarket Cap
126.46P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of AbbVie Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 245.00, with a high of 289.00 and a low of 187.64.
Analyst Rating
Based on
33
analysts
Buy
Current Rating
265.349
Target Price
+3.61%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
AbbVie Inc
ABBV
33
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
Merck & Co Inc
MRK
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is AbbVie Inc's expected revenue for the next quarter?
AbbVie Inc's expected revenue is 16.76B.
What is AbbVie Inc's price target?
Analysts forecast that AbbVie Inc's price target is USD 245.00, with the highest forecast at USD 289.00 and the lowest forecast at USD 187.64.
How have AbbVie IncABBV's recent earnings per share performed?
The market expectation was USD 0.39, while AbbVie IncABBV's earnings per share (EPS) for the previous quarter was USD 1.02. EPS for the next quarter is expected at USD 3.60.
What is the analyst rating for AbbVie Inc?
Based on the ratings of AbbVie Inc's stock from 33 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.